Published in Heart on December 13, 2010
Identification of recurring patterns in fractionated atrial electrograms using new transform coefficients. Biomed Eng Online (2012) 0.82
Human cardiac systems electrophysiology and arrhythmogenesis: iteration of experiment and computation. Europace (2014) 0.77
New Ablation Technologies and Techniques. Arrhythm Electrophysiol Rev (2014) 0.75
Better Lesion Creation And Assessment During Catheter Ablation. J Atr Fibrillation (2015) 0.75
Recent advances in rhythm control for atrial fibrillation. F1000Res (2017) 0.75
HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm (2010) 2.35
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. J Am Coll Cardiol (2009) 2.16
Achievement of pulmonary vein isolation in patients undergoing circumferential pulmonary vein ablation: a randomized comparison between two different isolation approaches. J Cardiovasc Electrophysiol (2006) 2.03
Relation of proximal aorta stiffness to left ventricular diastolic function in patients with end-stage renal disease. J Am Soc Echocardiogr (2007) 1.95
Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): results from a large multicenter prospective randomized trial. Circulation (2010) 1.91
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2006) 1.84
HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm (2008) 1.79
Defibrillation threshold testing: tradition or necessity? Pacing Clin Electrophysiol (2009) 1.65
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J (2008) 1.64
Anomalous collateral from the coronary artery to the affected lung in a case of congenital absence of the left pulmonary artery: effect on coronary circulation. Chest (2002) 1.64
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Rev Esp Cardiol (Engl Ed) (2014) 1.61
Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. Am J Cardiol (2007) 1.61
Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. Europace (2011) 1.57
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. Eur Heart J (2008) 1.57
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm (2012) 1.54
Ivabradine improves coronary flow reserve in patients with stable coronary artery disease. Atherosclerosis (2010) 1.53
Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation. J Cardiovasc Electrophysiol (2011) 1.52
Electrophysiological effects of carvedilol administration in patients with dilated cardiomyopathy. Cardiovasc Drugs Ther (2008) 1.52
Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study. Cardiovasc Drugs Ther (2003) 1.48
Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment. J Am Coll Cardiol (2010) 1.48
Transcatheter thrombolysis with high-dose bolus tissue plasminogen activator in iatrogenic arterial occlusion after femoral arterial catheterization. Cardiovasc Intervent Radiol (2002) 1.47
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace (2012) 1.46
Early cardiac gene transcript levels in peripheral blood mononuclear cells in patients with untreated essential hypertension. J Hypertens (2011) 1.44
Vascular endothelial growth factor protein levels and gene expression in peripheral monocytes after stenting: a randomized comparative study of sirolimus: eluting and bare metal stents. Eur Heart J (2008) 1.44
Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol (2007) 1.42
Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study. Hellenic J Cardiol (2005) 1.40
Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. N Engl J Med (2005) 1.26
Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology. Eur Heart J (2011) 1.25
Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover. J Am Coll Cardiol (2008) 1.18
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Eur J Heart Fail (2011) 1.16
Acute electrophysiologic effects of inhaled salbutamol in humans. Chest (2005) 1.10
An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality. Europace (2010) 1.08
Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks. Europace (2008) 1.05
Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review. ScientificWorldJournal (2012) 0.98
Correlation of mechanical dyssynchrony with QRS duration measured by signal-averaged electrocardiography. Ann Noninvasive Electrocardiol (2009) 0.98
Arrhythmia-induced cardiomyopathies: the riddle of the chicken and the egg still unanswered? Europace (2011) 0.96
Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation. Europace (2012) 0.95
Left ventricular mechanics during right ventricular apical or left ventricular-based pacing in patients with chronic atrial fibrillation after atrioventricular junction ablation. J Am Coll Cardiol (2004) 0.95
Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (2004) 0.93
Isolated left ventricular apical hypoplasia: a newly recognized unclassified cardiomyopathy. J Am Soc Echocardiogr (2010) 0.93
Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner. Basic Res Cardiol (2004) 0.91
Angiotensin II type 1 receptor inhibition is associated with reduced tachyarrhythmia-induced ventricular interstitial fibrosis in a goat atrial fibrillation model. Cardiovasc Drugs Ther (2007) 0.91
Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J (2004) 0.91
The European Society of Cardiology: priorities, projects, plans. Hellenic J Cardiol (2012) 0.91
Tracing the European course of cardiac resynchronization therapy from 2006 to 2008. Europace (2010) 0.91
Cost-effectiveness of atrial fibrillation catheter ablation. Europace (2008) 0.88
Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation. Am J Cardiol (2004) 0.87
Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines. Int J Cardiol (2005) 0.87
Androgen deficiency and endothelial dysfunction in men with end-stage kidney disease receiving maintenance hemodialysis. Am J Nephrol (2006) 0.87
Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med (2014) 0.87
Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects. Angiology (2006) 0.85
Quadricuspid aortic valve associated with non-obstructive sub-aortic membrane: a case report and review of the literature. Hellenic J Cardiol (2009) 0.85
Risk factors for ischaemic heart disease in a Cretan rural population: a twelve year follow-up study. BMC Public Health (2007) 0.85
Biochemical characterisation of Troponin C mutations causing hypertrophic and dilated cardiomyopathies. J Muscle Res Cell Motil (2014) 0.85
TLR2 and TLR4 gene expression in peripheral monocytes in nondiabetic hypertensive patients: the effect of intensive blood pressure-lowering. J Clin Hypertens (Greenwich) (2012) 0.85
Altered expression of early cardiac marker genes in circulating cells of patients with hypertrophic cardiomyopathy. Cardiovasc Pathol (2007) 0.85
Atrial fibrillation is associated with increased neurohumoral activation and reduced exercise tolerance in patients with non-ischemic dilated cardiomyopathy. Int J Cardiol (2006) 0.85
Carcinoid heart disease in a patient with primary ovarian carcinoid tumour. Hellenic J Cardiol (2007) 0.85
Ventricular special defect in the elderly: an uncommon clinical entity. Hellenic J Cardiol (2005) 0.84
Thyroxine pretreatment increases basal myocardial heat-shock protein 27 expression and accelerates translocation and phosphorylation of this protein upon ischaemia. Eur J Pharmacol (2003) 0.84
Acute coronary syndrome in an adult with anomalous origin of the left anterior descending coronary artery from the pulmonary trunk. Int J Cardiol (2007) 0.84
Differential effect of telmisartan and amlodipine on monocyte chemoattractant protein-1 and peroxisome proliferator-activated receptor-gamma gene expression in peripheral monocytes in patients with essential hypertension. Am J Cardiol (2011) 0.84
Moving from political declaration to action on reducing the global burden of cardiovascular diseases: a statement from the Global Cardiovascular Disease Taskforce. J Am Coll Cardiol (2013) 0.83
Atrial fibrillation, inflammation and statins. Hellenic J Cardiol (2006) 0.83
Autonomic nervous system changes in vasovagal syncope: is there any difference between young and older patients? Pacing Clin Electrophysiol (2004) 0.82
Continuous positive airway pressure therapy lowers vagal tone in patients with obstructive sleep apnoea-hypopnoea syndrome. Hellenic J Cardiol (2006) 0.82
Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study. Clin Res Cardiol (2009) 0.82
Mechanisms of arrhythmia recurrence after video-assisted thoracoscopic surgery for the treatment of atrial fibrillation: insights from electrophysiological mapping and ablation. J Cardiovasc Electrophysiol (2009) 0.82
Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation. Am J Cardiol (2010) 0.82
Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects. Curr Drug Targets Cardiovasc Haematol Disord (2005) 0.81
Epidemiological characteristics, management and early outcome of acute myocardial infarction in Greece: the HELlenic Infarction Observation Study. Hellenic J Cardiol (2008) 0.81
Primary heart angiosarcoma. Hellenic J Cardiol (2008) 0.81
Peripheral arterial embolism due to a left ventricular diverticulum in a young adult. Chest (2005) 0.81
Safety of implantable pacemakers and cardioverter defibrillators in the magnetic field of a novel remote magnetic navigation system. J Cardiovasc Electrophysiol (2010) 0.80
Enhanced tolerance of the rat myocardium to ischemia and reperfusion injury early after acute myocardial infarction. Basic Res Cardiol (2007) 0.80
Central aortic stiffness in patients with nonischemic dilated cardiomyopathy: relationship with neurohumoral activation. J Card Fail (2009) 0.80
Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation. J Am Coll Cardiol (2008) 0.80
Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study. Am Heart J (2005) 0.80
Inadequate heart rate control is associated with worse quality of life in patients with coronary artery disease and chronic obstructive pulmonary disease. The RYTHMOS study. Hellenic J Cardiol (2012) 0.80
High prevalence and diminished awareness of overweight and obesity in a mediterranean population. An alarming call for action. Open Cardiovasc Med J (2012) 0.80
Dobutamine administration exacerbates postischaemic myocardial dysfunction in isolated rat hearts: an effect reversed by thyroxine pretreatment. Eur J Pharmacol (2003) 0.80
Rationale and design of the OPTION study: optimal antitachycardia therapy in ICD patients without pacing indications. Pacing Clin Electrophysiol (2010) 0.80
A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation. Am J Cardiol (2007) 0.80
Combined use of aspiration catheter and distal embolisation protection device to facilitate angioplasty of a totally occluded saphenous vein graft. Hellenic J Cardiol (2007) 0.79
Thyroid hormone and cardioprotection: study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart. Mol Cell Biochem (2003) 0.79
Sleep-disordered breathing in heart failure and the effect of cardiac resynchronization therapy. Europace (2008) 0.79
Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1. Thyroid (2005) 0.79
Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation. Am J Cardiol (2004) 0.79